Skip to main content
. 2017 Mar 18;8(17):29202–29219. doi: 10.18632/oncotarget.16346

Figure 3. Survival curves of patients with different PLCE1 haplotypes and joint-effects analysis of different AFP levels.

Figure 3

(A) OS stratified by AC and GT haplotypes. (B–D) OS stratified by joint-effects analysis of PLCE1 haplotypes and an AFP cut-off level of 20 ng/ml (B), 200 ng/ml (C), and 400 ng/ml (D).